InnovaHealth Partners
InnovaHealth Partners is a New York City-based private equity firm founded in 2017 that pursues growth buyouts of late-stage medical device companies in the US, Europe, and Israel, taking controlling positions to accelerate commercialization and enable strategic exits.
- Company typePrivate
- Founded2016
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What InnovaHealth Partners does
InnovaHealth Partners is a New York City-based private investment firm founded in 2017 that concentrates on growth buyouts of late-stage medical technology companies. The firm targets controlling positions as sole or lead investor in medical device companies primarily located in the United States, Europe, and Israel, with active holdings spanning neurovascular intervention (Route 92 Medical), robotic neurosurgery (Monteris Medical), women's pelvic health (Materna Medical, Channel Medsystems), prostate cancer imaging and ablation (Koelis), and radiation protection (Radiaction). The firm has produced two confirmed strategic exits—Blue Belt (acquired by Smith & Nephew in 2015) and OrthoSpace (acquired by Stryker in 2019)—demonstrating a clear pathway to liquidity through strategic acquirers in the medical device sector.
The firm generates returns through equity investments in portfolio companies rather than through direct technology commercialization. Go-to-market activity centers on identifying later-stage opportunities involving disruptive medical device technologies, partnering with management teams to accelerate growth and execute on value creation. Pricing and investment terms are negotiated privately with each portfolio company and not publicly disclosed. Distribution is relationship-driven: the firm leverages longstanding ties to strategic acquirers, clinical and scientific advisors, regulatory and reimbursement experts, and industry executives to support sourcing, due diligence, and exit execution. Marketing channels include participation at major medical technology conferences (NASS, CNS, AUA, ESOC, DeviceTalks Boston), a webinar series featuring industry leaders, and a content/news platform branded as "IH Interests."
Leadership comprises Managing Partner & Founder Mortimer Berkowitz III and Partner & Founder John McCormick, supported by Senior Partner Toby Cosgrove, MD (former CEO of Cleveland Clinic), and Senior Advisors Richard B. Emmitt and Ariella Golomb, MD. The firm operates with a lean team of 1-10 employees from its headquarters at 570 Lexington Avenue, New York. AI/ML capability is not a core competency of the firm itself; however, portfolio company Koelis has developed AI-assisted auto-contouring software (ProMap Smart) using a hybrid ML/Model engine for prostate imaging.
InnovaHealth Partners firmographics
Firmographics- Name
- InnovaHealth Partners
- Legal name
- InnovaHealth Partners
- Website
- https://www.innovahealthpartners.com/
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- InnovaHealth Partners is a New York City-based private equity firm founded in 2017 that pursues growth buyouts of late-stage medical device companies in the US, Europe, and Israel, taking controlling positions to accelerate commercialization and enable strategic exits.
- Ownership category
- akta.pro rank
InnovaHealth Partners industry classification
Industry- Product category
- Medical Device Private Equity
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
Keywords
Where InnovaHealth Partners is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
InnovaHealth Partners business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Investment Returns: InnovaHealth generates returns through equity investments in medical device companies, partnering with management teams to build innovative, differentiated, and high-growth medical technology companies. The firm aims to acquire controlling positions in portfolio companies as the sole or lead investor, creating value for all stakeholders through strategic insight and capital.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
InnovaHealth Partners product offering
Product offeringCore offering
InnovaHealth Partners is a New York City-based private investment firm that concentrates on growth buyouts of established medical technology companies. The firm invests capital as sole or lead investor to acquire controlling positions, partnering with management teams to accelerate growth in medical device companies whose products address large unmet clinical needs across neurovascular, neurosurgery, women's health, urology, orthopedic, spine, and radiation protection sectors.
Differentiator
Problem solved
Functional benefit
Brands
- IH Interests: News and announcements section of InnovaHealth Partners covering industry insights, portfolio company updates, and webinar content.
Products and services
- Growth buyout equity capital for medical device companies Controlling equity capital and strategic partnership provided to late-stage medical technology companies in exchange for sole or lead investor positions, supporting growth and value creation through clinical, regulatory, reimbursement, and exit-readiness support.
Companies that use InnovaHealth Partners
Customer profileNamed customers6 records
Segments1 record
Ideal customer profiles1 record
InnovaHealth Partners technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
InnovaHealth Partners partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered clinical partnership and advisory.
- Koelis (with healthcare institutions)clinical partnershipKoelis collaborates with European healthcare institutions including Cochin Hospital (Paris), Bordet Cancer Institute (Brussels), Urology Clinic Atlantis (Nantes), Pellegrin Hospital (Bordeaux), Clinique Saint Augustin (Bordeaux), and American Hospital Paris for the VIOLETTE clinical trial on targeted microwave ablation for prostate cancer.
- Toby Cosgrove, MDadvisoryFormer Cleveland Clinic CEO Toby Cosgrove, MD serves as Senior Partner and Senior Advisor to InnovaHealth Partners, bringing extensive healthcare industry expertise and leadership.
- Richard B. EmmittadvisoryRichard B. Emmitt serves as Senior Advisor to InnovaHealth Partners, providing expertise in medical device investment and industry analysis.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
InnovaHealth Partners competitors and assessment
Company assessmentDirect peers
- Avista Capital Partners: Private equity firm with a dedicated healthcare practice investing in growth-stage pharmaceutical, medical device, and healthcare services companies. Comparable as a sector-focused PE investor underwriting similar late-stage medical technology assets.
- Trinity Hunt Partners: Growth-oriented private equity firm with a healthcare services and products vertical. Comparable as a lower-middle market healthcare sponsor investing in founder-owned growth companies with operating partnerships.
- DW Healthcare Partners: Healthcare-focused private equity firm investing exclusively in healthcare companies, with significant activity in medical devices. Comparable as a sector-specialized sponsor targeting controlling positions in growth-stage medtech businesses.
- Linden Capital Partners: Healthcare-focused middle-market private equity firm investing in medical products, services, and related businesses. Highly comparable as a sector-specialized healthcare PE sponsor targeting similar mid-to-late stage medtech companies with operating support.
- Frazier Healthcare Partners: Healthcare-focused private equity and venture firm investing across all stages of healthcare, including significant medical device activity. Comparable as a healthcare-dedicated capital partner with growth-stage investing capability.
- Ampersand Capital Partners: Specialty private equity firm focused exclusively on healthcare and life sciences companies, including medical devices, diagnostics, and pharma services. Comparable as a sector-specialist sponsor backing growth-stage healthcare businesses.
- Welsh, Carson, Anderson & Stowe: Long-standing private equity firm with one of the largest dedicated healthcare teams, actively investing in medical devices and healthcare services. Comparable as a sector-focused growth investor with deep medtech relationships.
- Chicago Pacific Founders: Healthcare-dedicated private equity firm founded by former healthcare executives, investing across healthcare services and medical technology. Comparable due to its operator-led model and focus on growth-stage healthcare opportunities.
Broad incumbents
- GTCR: Private equity firm with a long-standing healthcare sector practice and Leaders Strategy approach to backing healthcare executives. Comparable as a growth-oriented healthcare investor, though part of a larger diversified PE portfolio.
- KKR Health Care Strategic Growth: Growth equity strategy within KKR targeting high-growth healthcare companies, including medical devices. Comparable as a large-scale healthcare growth investor, though operating within a much broader generalist PE platform.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
InnovaHealth Partners social profiles
Digital presenceInnovaHealth Partners financial estimates
Financial estimateRevenue estimate
Valuation estimate
InnovaHealth Partners leadership team
Management profileNumber of profiles
Profiles5 records
InnovaHealth Partners funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
InnovaHealth Partners M&A and investment
M&A and investmentM&A1 record
Investments14 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about InnovaHealth Partners
What does InnovaHealth Partners do?
InnovaHealth Partners is a New York City-based private investment firm that concentrates on growth buyouts of established medical technology companies. The firm invests capital as sole or lead investor to acquire controlling positions, partnering with management teams to accelerate growth in medical device companies whose products address large unmet clinical needs across neurovascular, neurosurgery, women's health, urology, orthopedic, spine, and radiation protection sectors.
Is InnovaHealth Partners a public or private company?
InnovaHealth Partners is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was InnovaHealth Partners founded?
InnovaHealth Partners was founded in 2016. It employs 1 to 10 people.
Where is InnovaHealth Partners based?
InnovaHealth Partners is headquartered in New York, United States, in the North America region.
How does InnovaHealth Partners make money?
One revenue line is on record: investment Returns.
Who are InnovaHealth Partners's main competitors?
Direct peers on record are Avista Capital Partners, Trinity Hunt Partners, DW Healthcare Partners, Linden Capital Partners, Frazier Healthcare Partners, Ampersand Capital Partners, Welsh, Carson, Anderson & Stowe and Chicago Pacific Founders. Broad incumbents are GTCR and KKR Health Care Strategic Growth.
Does InnovaHealth Partners have an API?
No public API is recorded for InnovaHealth Partners.
What industry is InnovaHealth Partners in?
InnovaHealth Partners's product category is Medical Device Private Equity. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.